AUGMENTING WITHAFERIN-A'S ANTIPROLIFERATIVE POTENTIAL AGAINST EXPERIMENTAL HEPATOCELLULAR CARCINOMA
Global Journal of Medical and Pharmaceutical Sciences · 2023
DOI: 10.55640/gjmps-abcd08 ↗Kurz gefasst
Fachartikel in der Zeitschrift Global Journal of Medical and Pharmaceutical Sciences, 2023. Verfasst von B. Arun Babu.
Abstract (Originalsprache)
Hepatocellular carcinoma (HCC) remains a significant global health concern with limited treatment options. Withaferin-A (WA), a natural compound derived from Withania somnifera, has shown promising antiproliferative effects against various cancer types, including HCC. However, its efficacy as a standalone treatment for HCC is limited. This study investigates strategies to enhance the antiproliferative activity of Withaferin-A against experimental HCC models. Using in vitro and in vivo approaches, we evaluated the synergistic effects of Withaferin-A in combination with other compounds and treatments. Results indicate that combination therapy involving Withaferin-A demonstrates enhanced antiproliferative activity against HCC cells compared to Withaferin-A alone. Furthermore, in vivo studies using experimental HCC models confirm the efficacy of combination therapy in inhibiting tumor growth and improving survival outcomes. These findings highlight the potential of combination therapy involving Withaferin-A as a promising strategy for the treatment of hepatocellular carcinoma.
Zitieren
APA
Babu, B. A. (2023). AUGMENTING WITHAFERIN-A'S ANTIPROLIFERATIVE POTENTIAL AGAINST EXPERIMENTAL HEPATOCELLULAR CARCINOMA. Global Journal of Medical and Pharmaceutical Sciences. https://doi.org/10.55640/gjmps-abcd08
Vancouver
Babu BA. AUGMENTING WITHAFERIN-A'S ANTIPROLIFERATIVE POTENTIAL AGAINST EXPERIMENTAL HEPATOCELLULAR CARCINOMA. Global Journal of Medical and Pharmaceutical Sciences. 2023. doi:10.55640/gjmps-abcd08
BibTeX
@article{Babu2023,
author = {Babu, B. Arun},
title = {AUGMENTING WITHAFERIN-A'S ANTIPROLIFERATIVE POTENTIAL AGAINST EXPERIMENTAL HEPATOCELLULAR CARCINOMA},
journal = {Global Journal of Medical and Pharmaceutical Sciences},
year = {2023},
doi = {10.55640/gjmps-abcd08}
}
EUVIMED